Véronique Leblond, MD, is a professor of hematology and the head of the Department of Hematology at Pitié-Salpêtrière Hospital in Paris, France. She is the chair of the French Innovative Leukemia Organization, which is involved in acute leukemia, chronic lymphocytic leukemia (CLL), and Waldenström’s macroglobulinemia (WM), including more than 90 centers in France.